


Ask a doctor about a prescription for ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
AlmotriptanKern Pharma12.5 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Almotriptan Kern Pharma is an antimigraine drug that belongs to a class of compounds known as selective serotonin receptor agonists. It is believed that Almotriptan Kern Pharma reduces the inflammatory response associated with migraines by binding to serotonin receptors in cerebral blood vessels (cranial), causing vasoconstriction.
Almotriptan Kern Pharma is used to relieve headache pain associated with migraine attacks with or without aura.
Do not take AlmotriptanKernPharma
Warnings and precautions
Consult your doctor or pharmacist before starting to take Almotriptan Kern Pharma:
It has been suggested that excessive use of antimigraine medicines may lead to chronic headache.
Children and adolescents
Children under 18 years old should not take Almotriptan Kern Pharma.
Over 65 years of age
If you are over 65 years old, you should consult your doctor before taking this medicine.
Taking AlmotriptanKernPharmawith other medicines
Tell your doctor or pharmacist if you are using or have recently used or may need to use any other medicine.
Please inform your doctor:
Almotriptan should not be taken at the same time as other medicines that contain ergotamine, which are also used to treat migraine. However, both medicines can be taken one after the other, provided that a minimum amount of time has passed between doses:
AlmotriptanKern Pharmawith food and drink
Almotriptan Kern Pharma can be taken with or without food.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
There is only limited information available on the use of almotriptan during pregnancy. Almotriptan Kern Pharma should only be used during pregnancy if prescribed by your doctor and only after carefully considering the balance of benefits and risks.
Cautious use is required when using this medicine during breastfeeding. You should avoid breastfeeding during the 24 hours following treatment.
Driving and using machines
This medicine, like migraine, can cause drowsiness. If you experience these effects, avoid driving or using machines, as it can be dangerous.
Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again.
Almotriptan Kern Pharma should only be used to treat a migraine attack that has already occurred and not to prevent migraine attacks or headaches.
Adults (18-65 years)
The recommended dose is one Almotriptan Kern Pharma tablet (12.5 mg of almotriptan) that should be taken as soon as possible after the onset of a migraine attack. If the attack does not subside, do not take more than one tablet.
If you experience a second attack within the next 24 hours, you can take a second 12.5 mg tablet, but always provided that at least 2 hours have passed between the first and second tablet.
The maximum daily dose is two 12.5 mg tablets in 24 hours.
The tablets can be taken with liquid (e.g. water) and can be taken with or without food.
Almotriptan Kern Pharma should be taken as soon as possible after the onset of a migraine attack, although it is also effective if taken later.
Severe kidney disease
If you have severe kidney disease, do not take more than one 12.5 mg tablet in 24 hours.
If you take more AlmotriptanKernPharmathan you should
If you accidentally take too many Almotriptan Kern Pharma tablets, or if someone else or a child takes this medicine, consult your doctor or pharmacist immediately.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Telephone 915 620 420, indicating the medicine and the amount ingested.
If you forget to take AlmotriptanKernPharma
Try to take Almotriptan Kern Pharma as prescribed. Do not take a double dose to make up for forgotten doses.
If you have any doubts about the use of Almotriptan Kern Pharma, consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from the available data)
Tell your doctor immediately if you experience:
Chest pain, tightness in the chest or throat, or any other symptom that may suggest a heart attack. Please inform your doctor immediately and do not take any further Almotriptan Kern Pharma tablets.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines (Website: www.notificaRAM.es).
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
No special storage conditions are required.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of AlmotriptanKern Pharma12.5 mg film-coated tablets
Appearance and packaging
Almotriptan Kern Pharma 12.5 mg film-coated tablets are available in packs of 4 and 6 tablets.
White, circular, biconvex film-coated tablets.
Marketing authorisation holder
Kern Pharma, S.L.
Polígono Ind. Colón II. Venus 72
08228 Terrassa (Barcelona)
Manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (SPAIN)
Date of last revision of this leaflet:June 2013
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS in October, 2025 is around 19.53 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ALMOTRIPTAN KERN PHARMA 12.5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.